Semaglutide vs Tirzepatide: Complete Comparison
Wondering how Semaglutide and Tirzepatide compare? This guide breaks down the key differences in ingredients, dosing, FDA approvals, and who each medication may be best suited for. Use the comparison below to have an informed conversation with your healthcare provider.
Side-by-Side Comparison
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Generic Name | semaglutide | tirzepatide |
| Molecule Type | GLP-1 receptor agonist | Dual GIP/GLP-1 receptor agonist |
| Manufacturer | Various (compounded/generic) | Various (compounded/generic) |
| FDA Approval | Varies by formulation | Varies by formulation |
| Available Doses | Custom (compounded doses vary) | Custom (compounded doses vary) |
| Half-Life | ~7 days | ~5 days |
| Dosing Frequency | Once weekly | Once weekly |
Key Differences
- •Semaglutide is a GLP-1 receptor agonist, while tirzepatide is a dual GIP/GLP-1 receptor agonist - the key pharmacological distinction.
- •Tirzepatide has demonstrated greater average weight loss and A1C reduction in clinical trials compared to semaglutide.
- •Semaglutide has a longer half-life (~7 days) than tirzepatide (~5 days), though both support weekly dosing.
- •Semaglutide has been available longer with more extensive long-term safety data from branded versions (Ozempic since 2017).
- •Tirzepatide's dual mechanism activates GIP receptors in addition to GLP-1, which may enhance insulin secretion and fat metabolism beyond what GLP-1-only therapy achieves.
Who Should Consider Each Medication?
Who May Prefer Semaglutide
Patients who want a well-studied molecule with extensive real-world data, those who respond well to GLP-1 monotherapy, or patients looking for potentially lower-cost compounded options.
Who May Prefer Tirzepatide
Patients seeking potentially greater efficacy through dual-receptor activation, those who have plateaued on semaglutide, or patients who want more dose titration options.
Track Either Medication with JellyPal
Whether you choose Semaglutide or Tirzepatide, JellyPal helps you track injections, visualize medication levels, monitor side effects, and share reports with your doctor. Our pharmacokinetic plotter uses each medication's specific half-life for accurate level modeling.
This comparison is for informational purposes only and is not medical advice. Both Semaglutide and Tirzepatide are prescription medications that should only be taken under the supervision of a qualified healthcare provider. Consult your doctor to determine which medication is appropriate for your individual needs.
Frequently Asked Questions
Start tracking your medication journey
Whether you take Semaglutide or Tirzepatide, JellyPal helps you understand your medication, track side effects, and optimize your health journey.